Skip to main content
CELADON PHARMACEUTICALS PLC logo

CELADON PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · CEL ISIN · GB00BDQYGP38 LEI · 213800YXCATORT475807 IL Manufacturing
Open in API
Filings indexed 128 across all filing types
Latest filing 2020-12-23 Regulatory Filings
Country GB United Kingdom
Listing IL CEL

About CELADON PHARMACEUTICALS PLC

https://celadonpharma.co.uk/

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.

Recent filings

Filing Released Lang Actions
Posting of Circular, Notice of GM and RPT
Regulatory Filings Classification · 98% confidence The document is an announcement from Summerway Capital PLC regarding the posting of a circular and notice of a General Meeting. It details the agenda for the meeting, including amendments to the investing policy, board changes, and a related party transaction. While it mentions the circular, the document itself is an RNS (Regulatory News Service) announcement serving as a formal notification to shareholders about the upcoming meeting and the availability of the circular. It fits the definition of a Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on upcoming resolutions, including proxy instructions.
2020-12-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 100% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Second Price Monitoring Extension' for Summerway Capital PLC. It is a standard market regulatory announcement regarding trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2020-12-18 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for Summerway Capital PLC. It is a standard automated regulatory announcement concerning trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2020-12-18 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Summerway Capital PLC. It is a standard market regulatory announcement concerning trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, M&A, or share issues, it falls under the general regulatory filing category.
2020-12-16 English
Price Monitoring Extension
Regulatory Filings Classification · 100% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for a specific security. It does not contain financial statements, management reports, or corporate governance disclosures. As it is a standard regulatory notification regarding trading mechanics that does not fit into specific categories like M&A or dividends, it falls under the RNS (Regulatory Filings) category.
2020-12-16 English
Investing Policy, Board Changes and Placing
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Summerway Capital PLC. It details multiple corporate actions: a proposed change to the company's investing policy, significant changes to the Board of Directors (appointments and resignations), and a proposed share placing and warrant issuance. Because it covers multiple strategic and governance updates simultaneously, it is best classified as a general regulatory filing. It is not a report itself, but an announcement of these changes and the future intent to issue a circular.
2020-12-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.